HAL (France)open access
HIF1 inhibition targets tumoral and myeloid cells, and is a promising therapy for metastatic castration-resistant prostate cancer
HIF1, Liver metastatic niches, 0, CCR2⁺ myeloid cell, TREM2⁺ macrophages, Neutrophils, 2, 1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 377974
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.